pentobarbital will decrease the level or effect of atogepant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Advisable atogepant dosage with concomitant utilization of sturdy or average CYP3A4 inducers is 30 mg or sixty mg qDay.pentobarbital will decrease the level or result of cilostazol by influen